These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5602957)

  • 41. [The partial thromboplastin test in the preoperative "screening" of hemorrhagic patients].
    Bracali G; Niccoli Vallesi R; Rubertelli M
    Ann Laringol Otol Rinol Faringol; 1967; 66(3):333-7. PubMed ID: 5632636
    [No Abstract]   [Full Text] [Related]  

  • 42. Kaolin partial thromboplastin time: high levels of procoagulants producing short clotting times or masking deficiencies of other procoagulants or low concentrations of anticoagulants.
    Edson JR; Krivit W; White JG
    J Lab Clin Med; 1967 Sep; 70(3):463-70. PubMed ID: 6072020
    [No Abstract]   [Full Text] [Related]  

  • 43. Platelet coagulation-protein interactions.
    Walsh PN
    Semin Thromb Hemost; 2004 Aug; 30(4):461-71. PubMed ID: 15354267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Protein S deficiency, acute phase reaction and thrombosis].
    Odegaard OR; Try K; Ly B; Gundersen T; Linnebo S
    Tidsskr Nor Laegeforen; 1993 Nov; 113(28):3460-3. PubMed ID: 7505957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [VENOUS THROMBOSIS AND OCCULT CANCER].
    BARRANTES NE
    Sem Med; 1963 Sep; 123():869-71. PubMed ID: 14093420
    [No Abstract]   [Full Text] [Related]  

  • 46. Deep vein thrombosis: the risks of sclerotherapy in hypercoagulable states.
    Feied CF
    Semin Dermatol; 1993 Jun; 12(2):135-49. PubMed ID: 8512794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The hemolytic complement activity in thrombophlebitis and thrombosis].
    PERLICK E; GOETZE I
    Arztl Forsch; 1954 Apr; 8(4):I/158-60. PubMed ID: 13171181
    [No Abstract]   [Full Text] [Related]  

  • 48. [Determination of thromboplastin hyperactivity].
    Smolianitskiĭ AIa
    Lab Delo; 1970; 4():254-5. PubMed ID: 4099481
    [No Abstract]   [Full Text] [Related]  

  • 49. A classification of disorders of hemostasis and thrombosis in patients with malignancy.
    Schmaier AH; Day HJ
    Prog Clin Biol Res; 1982; 89():1-20. PubMed ID: 7111293
    [No Abstract]   [Full Text] [Related]  

  • 50. [DIAGNOSIS OF DISORDERS OF THROMBOPLASTIN FORMATION].
    YAMADA S
    Rinsho Byori; 1964 Oct; 12():527-32. PubMed ID: 14278273
    [No Abstract]   [Full Text] [Related]  

  • 51. Types of AT III abnormalities and their significance in hypercoagulability.
    Nagy I; Losonczy H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):421-5. PubMed ID: 6083906
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hemostatic status in subjects with deep venous thrombosis].
    Ferlito S; Bonomo T; Pitari G; Puleo R; Condorelli M; Mazzone D
    Minerva Cardioangiol; 1996 Dec; 44(12):649-53. PubMed ID: 9053819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical course study in thrombophilia].
    Kühnel L; Heinrichs C
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):519-27. PubMed ID: 6083922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thrombophilia: some recent advances in understanding.
    James CM
    J R Nav Med Serv; 1995; 81(3):203-6. PubMed ID: 8736314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Procedure-dependence and tissue factor-independence of hypercoagulability during orthopaedic surgery.
    Fedi S; Gori AM; Falciani M; Cellai AP; Aglietti P; Baldini A; Vena LM; Prisco D; Abbate R; Gensini GF
    Thromb Haemost; 1999 Jun; 81(6):874-8. PubMed ID: 10404760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR; Pyke S; Iannaccone L; Brancaccio V
    Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abstracts: IX International Congress on Thrombosis and Haemostasis. 4-8 July 1983.
    Thromb Haemost; 1983 Jul; 50(1):1-508. PubMed ID: 6623428
    [No Abstract]   [Full Text] [Related]  

  • 59. Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism.
    Angles-Cano E; Gris JC; Loyau S; Schved JF
    J Lab Clin Med; 1993 May; 121(5):646-53. PubMed ID: 8478593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activated partial thromboplastin time: results of a case-control study evaluating six commercial reagents in assessing the risk of venous thromboembolism.
    Tripodi A; Chantarangkul V; Asti D; Martinelli I; Mannucci PM
    J Thromb Haemost; 2006 Jun; 4(6):1407-9. PubMed ID: 16706989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.